ScoreWhy is Tianjin Tianyao Pharmaceuticals Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 4.51%
- The company has been able to generate a Return on Capital Employed (avg) of 4.51% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of -0.13% and Operating profit at -8.32% over the last 5 years
3
With a fall in PBT of -16.45%, the company declared Very Negative results in Sep 25
- The company has declared negative results for the last 2 consecutive quarters
- The company has declared negative results in Dec 24 after 2 consecutive negative quarters
- NET PROFIT(HY) At CNY 11.49 MM has Grown at -91.07%
- OPERATING CASH FLOW(Y) Lowest at CNY 150.11 MM
- ROCE(HY) Lowest at 0.54%
4
With ROE of 3.83%, it has a expensive valuation with a 1.48 Price to Book Value
- Over the past year, while the stock has generated a return of -2.81%, its profits have fallen by -37.5%
- At the current price, the company has a high dividend yield of 2.4
5
Below par performance in long term as well as near term
- Along with generating -2.81% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Tianjin Tianyao Pharmaceuticals Co., Ltd. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Tianjin Tianyao Pharmaceuticals Co., Ltd.
20.63%
0.51
21.30%
China Shanghai Composite
23.91%
1.58
14.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-3.12%
EBIT Growth (5y)
-6.61%
EBIT to Interest (avg)
4.55
Debt to EBITDA (avg)
1.82
Net Debt to Equity (avg)
0.02
Sales to Capital Employed (avg)
0.83
Tax Ratio
6.47%
Dividend Payout Ratio
80.50%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.51%
ROE (avg)
3.94%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
91
Industry P/E
Price to Book Value
1.85
EV to EBIT
46.49
EV to EBITDA
16.57
EV to Capital Employed
1.84
EV to Sales
2.08
PEG Ratio
NA
Dividend Yield
1.90%
ROCE (Latest)
3.96%
ROE (Latest)
2.03%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend8What is working for the Company
NET PROFIT(HY)
At CNY 14.92 MM has Grown at 210.4%
RAW MATERIAL COST(Y)
Fallen by -9.9% (YoY
CASH AND EQV(HY)
Highest at CNY 1,527.17 MM
DEBT-EQUITY RATIO
(HY)
Lowest at 1.8 %
INVENTORY TURNOVER RATIO(HY)
Highest at 2.62 times
-20What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at CNY 137.32 MM
NET PROFIT(9M)
At CNY 35.15 MM has Grown at -28.96%
INTEREST COVERAGE RATIO(Q)
Lowest at 498.2
DEBTORS TURNOVER RATIO(HY)
Lowest at 4.01 times
NET SALES(Q)
Lowest at CNY 608.11 MM
OPERATING PROFIT(Q)
Lowest at CNY 24.13 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 3.97 %
PRE-TAX PROFIT(Q)
At CNY 21.42 MM has Fallen at -31.2%
Here's what is working for Tianjin Tianyao Pharmaceuticals Co., Ltd.
Net Profit
At CNY 14.92 MM has Grown at 210.4%
Year on Year (YoY)MOJO Watch
Net Profit trend is very positive
Net Profit (CNY MM)
Cash and Eqv
Highest at CNY 1,527.17 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio
Lowest at 1.8 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Inventory Turnover Ratio
Highest at 2.62 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -9.9% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Tianjin Tianyao Pharmaceuticals Co., Ltd.
Net Sales
At CNY 608.11 MM has Fallen at -16.35%
over average net sales of the previous four periods of CNY 727.01 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (CNY MM)
Operating Cash Flow
Lowest at CNY 137.32 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Interest Coverage Ratio
Lowest at 498.2
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Net Sales
Lowest at CNY 608.11 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Operating Profit
Lowest at CNY 24.13 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at 3.97 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Pre-Tax Profit
At CNY 21.42 MM has Fallen at -31.2%
over average net sales of the previous four periods of CNY 31.13 MMMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (CNY MM)
Debtors Turnover Ratio
Lowest at 4.01 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
